BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in BioCardia, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −2 vs. Q4 2022
- Shares held
- 2.09M
- −238.8K (−10.2%) vs. Q4 2022
- Total value
- $4.09M
- −$785.1K (−16.1%) vs. Q4 2022
- New holders
- 1
- 4 more added
- Sold out
- 3
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 87 | $170 | 0.00% | +2+2.4% | Added |
| Aspire Private Capital, LLC | 300 | $585 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 983 | $1.92K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,047 | $2.04K | 0.00% | −6,801−86.7% | Reduced |
| Tower Research Capital LLC (TRC) | 2,105 | $4.00K | 0.00% | +1,005+91.4% | Added |
| Bank of America Corp | 6,528 | $12.7K | 0.00% | −26−0.4% | Reduced |
| LPL Financial LLC | 11,050 | $21.5K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,668 | $24.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 15,600 | $30.0K | 0.00% | +1,500+10.6% | Added |
| Vontobel Holding Ltd. | 15,895 | $31.2K | 0.00% | +15,895 | New |
| Northern Trust Corp | 19,226 | $37.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,000 | $41.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 22,183 | $43.5K | 0.00% | +10,606+91.6% | Added |
| Brown Advisory Inc | 33,085 | $64.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 43,696 | $85.6K | 0.00% | −69,130−61.3% | Reduced |
| Advisor Group Holdings, Inc. | 46,843 | $91.3K | 0.00% | −1,000−2.1% | Reduced |
| Commonwealth Equity Services, LLC | 52,978 | $103.0K | 0.00% | 00.0% | Unchanged |
| Family Management Corp | 77,500 | $151.1K | 0.03% | −64,800−45.5% | Reduced |
| Geode Capital Management, LLC | 96,594 | $189.3K | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 125,600 | $246.2K | 0.12% | −20,828−14.2% | Reduced |
| CM Management, LLC | 329,000 | $642.0K | 0.76% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 509,151 | $994.1K | 0.37% | −86,086−14.5% | Reduced |
| Vanguard Group Inc | 650,763 | $1.27M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,536−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,543−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |